Form 4 for MDT Medtronic
Accepted 2026-02-26 00:00:00 ET · period of report 2026-02-19 · accession 0001708062-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-26 | 2026-02-19 | MDT | KIIL HARRY SKIP | EVP, Pres Cardiovascular | S - Sale+OE | $97.71 | -52.5K | 33.2K | -61% | -$5.13M |
| DM | 2026-02-26 | 2026-02-19 | MDT | KIIL HARRY SKIP | EVP, Pres Cardiovascular | M - OptEx | $90.90 | +50.9K | 65.0K | +361% | +$4.62M |
| DM | 2026-02-26 | 2026-02-19 | MDT | KIIL HARRY SKIP | EVP, Pres Cardiovascular | M - OptEx | $0.00 | -50.9K | 11.6K | -81% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-02-19 | S | D | 30,568 | $97.66 | 53,076 | D | — | — | (F2) The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $97.60 to $97.775. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request. |
| 2 | Common | Ordinary Shares | 2026-02-19 | S | D | 19,255 | $97.77 | 33,821 | D | — | — | |
| 3 | Common | Ordinary Shares | 2026-02-19 | S | D | 385 | $97.82 | 32,768 | D | — | — | |
| 4 | Common | Ordinary Shares | 2026-02-19 | S | D | 1,648 | $97.86 | 83,644 | D | — | — | |
| 5 | Common | Ordinary Shares | 2026-02-19 | M | A | 385 | $80.00 | 85,292 | D | — | — | |
| 6 | Common | Ordinary Shares | 2026-02-19 | M | A | 19,923 | $87.76 | 84,907 | D | — | — | |
| 7 | Common | Ordinary Shares | 2026-02-19 | M | A | 30,568 | $93.08 | 64,984 | D | — | — | (F1) Includes 239 shares acquired through dividend reinvestment since the last report filed by the reporting person. |
| 8 | Common | Ordinary Shares | 2026-02-19 | S | D | 668 | $97.83 | 33,153 | D | — | — | |
| 9 | Derivative | Stock Option (Right to Buy) | 2026-02-19 | M | D | 385 | $0.00 | 1,155 | D | $80.00 · 2025-07-29 to 2034-07-29 | 385 Ordinary Shares | |
| 10 | Derivative | Stock Option (Right to Buy) | 2026-02-19 | M | D | 19,923 | $0.00 | 18,926 | D | $87.76 · 2024-07-31 to 2033-07-31 | 19,923 Ordinary Shares | |
| 11 | Derivative | Stock Option (Right to Buy) | 2026-02-19 | M | D | 30,568 | $0.00 | 11,606 | D | $93.08 · 2023-08-01 to 2032-08-01 | 30,568 Ordinary Shares |